SEC Info℠  
    Home      Search      My Interests      Help      Sign In      Please Sign In

Xenetic Biosciences, Inc. – ‘8-K’ for 3/22/24 – ‘XML’

On:  Friday, 3/22/24, at 8:00am ET   ·   For:  3/22/24   ·   Accession #:  1683168-24-1606   ·   File #:  1-37937

Previous ‘8-K’:  ‘8-K’ on / for 2/12/24   ·   Next & Latest:  ‘8-K’ on / for 5/10/24

Find Words in Filings emoji
 		  in    Show  and   ↓Hints

  As Of               Filer                 Filing    For·On·As Docs:Size             Issuer                      Filing Agent

 3/22/24  Xenetic Biosciences, Inc.         8-K:2,9     3/22/24   12:257K                                   GlobalOne Filings Inc/FA

Current Report   —   Form 8-K

Filing Table of Contents

Document/Exhibit                   Description                      Pages   Size 

 1: 8-K         Current Report                                      HTML     32K 
 2: EX-99.1     Press Release                                       HTML     15K 
 7: R1          Cover                                               HTML     48K 
 9: XML         IDEA XML File -- Filing Summary                      XML     12K 
12: XML         XBRL Instance -- xenetic_8k_htm                      XML     20K 
 8: EXCEL       IDEA Workbook of Financial Report Info              XLSX      8K 
 4: EX-101.DEF  XBRL Definitions -- xbio-20240322_def                XML     73K 
 5: EX-101.LAB  XBRL Labels -- xbio-20240322_lab                     XML    102K 
 6: EX-101.PRE  XBRL Presentations -- xbio-20240322_pre              XML     70K 
 3: EX-101.SCH  XBRL Schema -- xbio-20240322                         XSD     14K 
10: JSON        XBRL Instance as JSON Data -- MetaLinks               27±    36K 
11: ZIP         XBRL Zipped Folder -- 0001683168-24-001606-xbrl      Zip     25K

‘XML’   —   XBRL Instance — xenetic_8k_htm

This Document is an XBRL File.

                                                                                                                                                                                
<?xml version="1.0" encoding="windows-1252"?>
<xbrl xmlns="http://www.xbrl.org/2003/instance" xmlns:XBIO="http://xeneticbio.com/20240322" xmlns:dei="http://xbrl.sec.gov/dei/2023" xmlns:iso4217="http://www.xbrl.org/2003/iso4217" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:us-gaap="http://fasb.org/us-gaap/2023" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns:xlink="http://www.w3.org/1999/xlink">
<link:schemaRef xlink:href="xbio-20240322.xsd" xlink:type="simple"/>
<context id="AsOf2024-03-22">
<entity>
<identifier scheme="http://www.sec.gov/CIK"> 0001534525 </identifier>
</entity>
<period>
<startDate> 2024-03-22 </startDate>
<endDate> 2024-03-22 </endDate>
</period>
</context>
<context id="From2024-03-222024-03-22_custom_CommonStock0.001ParValuePerShareMember">
<entity>
<identifier scheme="http://www.sec.gov/CIK"> 0001534525 </identifier>
<segment>
<xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis"> XBIO:CommonStock0.001ParValuePerShareMember </xbrldi:explicitMember>
</segment>
</entity>
<period>
<startDate> 2024-03-22 </startDate>
<endDate> 2024-03-22 </endDate>
</period>
</context>
<context id="From2024-03-222024-03-22_custom_PurchaseWarrantsMember">
<entity>
<identifier scheme="http://www.sec.gov/CIK"> 0001534525 </identifier>
<segment>
<xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis"> XBIO:PurchaseWarrantsMember </xbrldi:explicitMember>
</segment>
</entity>
<period>
<startDate> 2024-03-22 </startDate>
<endDate> 2024-03-22 </endDate>
</period>
</context>
<unit id="USD">
<measure> iso4217:USD </measure>
</unit>
<unit id="Shares">
<measure> shares </measure>
</unit>
<unit id="USDPShares">
<divide>
<unitNumerator>
<measure> iso4217:USD </measure>
</unitNumerator>
<unitDenominator>
<measure> shares </measure>
</unitDenominator>
</divide>
</unit>
<dei:AmendmentFlag contextRef="AsOf2024-03-22" id="Fact000003"> false </dei:AmendmentFlag>
<dei:EntityCentralIndexKey contextRef="AsOf2024-03-22" id="Fact000004"> 0001534525 </dei:EntityCentralIndexKey>
<dei:DocumentType contextRef="AsOf2024-03-22" id="Fact000009"> 8-K </dei:DocumentType>
<dei:DocumentPeriodEndDate contextRef="AsOf2024-03-22" id="Fact000010"> 2024-03-22 </dei:DocumentPeriodEndDate>
<dei:EntityRegistrantName contextRef="AsOf2024-03-22" id="Fact000011"> Xenetic Biosciences, Inc. </dei:EntityRegistrantName>
<dei:EntityIncorporationStateCountryCode contextRef="AsOf2024-03-22" id="Fact000012"> NV </dei:EntityIncorporationStateCountryCode>
<dei:EntityFileNumber contextRef="AsOf2024-03-22" id="Fact000013"> 001-37937 </dei:EntityFileNumber>
<dei:EntityTaxIdentificationNumber contextRef="AsOf2024-03-22" id="Fact000014"> 45-2952962 </dei:EntityTaxIdentificationNumber>
<dei:EntityAddressAddressLine1 contextRef="AsOf2024-03-22" id="Fact000015"> 945 Concord Street </dei:EntityAddressAddressLine1>
<dei:EntityAddressCityOrTown contextRef="AsOf2024-03-22" id="Fact000016"> Framingham </dei:EntityAddressCityOrTown>
<dei:EntityAddressStateOrProvince contextRef="AsOf2024-03-22" id="Fact000017"> MA </dei:EntityAddressStateOrProvince>
<dei:EntityAddressPostalZipCode contextRef="AsOf2024-03-22" id="Fact000018"> 01701 </dei:EntityAddressPostalZipCode>
<dei:CityAreaCode contextRef="AsOf2024-03-22" id="Fact000019"> (781) </dei:CityAreaCode>
<dei:LocalPhoneNumber contextRef="AsOf2024-03-22" id="Fact000020"> 778-7720 </dei:LocalPhoneNumber>
<dei:WrittenCommunications contextRef="AsOf2024-03-22" id="Fact000021"> false </dei:WrittenCommunications>
<dei:SolicitingMaterial contextRef="AsOf2024-03-22" id="Fact000022"> false </dei:SolicitingMaterial>
<dei:PreCommencementTenderOffer contextRef="AsOf2024-03-22" id="Fact000023"> false </dei:PreCommencementTenderOffer>
<dei:PreCommencementIssuerTenderOffer contextRef="AsOf2024-03-22" id="Fact000024"> false </dei:PreCommencementIssuerTenderOffer>
<dei:Security12bTitle contextRef="From2024-03-222024-03-22_custom_CommonStock0.001ParValuePerShareMember" id="Fact000025"> Common Stock, $0.001 par value per share </dei:Security12bTitle>
<dei:TradingSymbol contextRef="From2024-03-222024-03-22_custom_CommonStock0.001ParValuePerShareMember" id="Fact000026"> XBIO </dei:TradingSymbol>
<dei:SecurityExchangeName contextRef="From2024-03-222024-03-22_custom_CommonStock0.001ParValuePerShareMember" id="Fact000027"> NASDAQ </dei:SecurityExchangeName>
<dei:Security12bTitle contextRef="From2024-03-222024-03-22_custom_PurchaseWarrantsMember" id="Fact000028"> Purchase Warrants </dei:Security12bTitle>
<dei:TradingSymbol contextRef="From2024-03-222024-03-22_custom_PurchaseWarrantsMember" id="Fact000029"> XBIOW </dei:TradingSymbol>
<dei:SecurityExchangeName contextRef="From2024-03-222024-03-22_custom_PurchaseWarrantsMember" id="Fact000030"> NASDAQ </dei:SecurityExchangeName>
<dei:EntityEmergingGrowthCompany contextRef="AsOf2024-03-22" id="Fact000031"> false </dei:EntityEmergingGrowthCompany>
</xbrl>

↑Top
Filing Submission 0001683168-24-001606   –   Alternative Formats (Word / Rich Text, HTML, Plain Text, et al.)
Copyright © 2024 Fran Finnegan & Company LLC – All Rights Reserved.
About — Privacy — Redactions — Help — Tue., May 14, 5:22:01.1am ET